Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorUniversity of Zurich
About this trial
LIMITFOOD2 is a randomized clinical intervention study that investigates the effects of two different intermittent fasting protocols compared to a control group on the health of obese adults. A total of 90 participants will be randomized into three equally sized groups: a modified alternate day fasting, a time-restricted eating and a control group, receiving general weight-loss counseling.
Eligibility criteria
Qualifiers
Age between 18-50 years, both inclusive
Obese, BMI between 30 and 40 kg/m² (obesity grade I or II), both inclusive
Non-smoker
Good knowledge of German or English language
Disqualifiers
Participants who have a fasting period of > 12h per day on a regular basis and do not eat at least three main meals per day.
Current habitual use of dietary supplements (e.g., vitamins, minerals) and/or unwillingness to cease intake of dietary supplements.
Antibiotics intake during 3 months prior to the study due to possible interference with metabolic parameters
Food intolerances, allergies and sensitivities (severe food allergies) or dietary restrictions (e.g. vegan lifestyle)
Trial design
Treatments tested in this trial
- Modified Alternate Day Fasting
- Time-Restricted Eating
- Weight-loss counseling
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov